Date | Price Target | Rating | Analyst |
---|---|---|---|
1/3/2024 | $7.00 | Underweight | Barclays |
5/15/2023 | $8.00 → $9.00 | Outperform → Market Perform | TD Cowen |
1/6/2023 | $8.00 | Equal-Weight → Overweight | Morgan Stanley |
11/7/2022 | $7.25 | Buy | Jefferies |
3/17/2022 | $19.00 → $10.00 | Buy → Neutral | UBS |
12/17/2021 | $15.00 → $10.00 | Equal-Weight | Morgan Stanley |
11/9/2021 | $24.00 → $12.00 | Overweight → Neutral | JP Morgan |
9/10/2021 | $18.00 | Outperform | Cowen & Co. |
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SCOTTSDALE, Ariz., Aug. 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 22nd Annual Morgan Stanley Global Healthcare Conference, which will be hosted in New York City, NY. Details of the presentation are as follows:Presenters: Dave Bourdon, CFODate: Wednesday, September 4, 2023 Time: 10:00 a.m. (Eastern time)Moderated by: Craig Hettenbach The presentation will be webcast live and will be available on the Events and Presentations section of the LifeStance Health Investor Relations website (https://investor.lifestance.com). A repl
Survey Also Reveals Differing Attitudes About Mental Health Content on Social Media, With TikTok Emerging as a Highly Used but Less Trusted Platform SCOTTSDALE, Ariz., Aug. 1, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today released findings from a new survey examining the state of Americans' mental health, their ability to access mental healthcare, how therapy ranks in their overall household budgets and the role that social media plays in shaping attitudes towards mental health. As the
SCOTTSDALE, Ariz., July 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2024 earnings release before the market opens on Thursday, August 8, 2024. LifeStance will host a live earnings conference call to discuss second quarter results on August 8, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 1488997, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance
Barclays initiated coverage of LifeStance Health Group with a rating of Underweight and set a new price target of $7.00
TD Cowen downgraded LifeStance Health Group from Outperform to Market Perform and set a new price target of $9.00 from $8.00 previously
Morgan Stanley upgraded LifeStance Health Group from Equal-Weight to Overweight and set a new price target of $8.00
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)
8-K - LifeStance Health Group, Inc. (0001845257) (Filer)
8-K - LifeStance Health Group, Inc. (0001845257) (Filer)
LifeStance Health Gr's (NYSE:LFST) short percent of float has fallen 5.99% since its last report. The company recently reported that it has 16.01 million shares sold short, which is 20.1% of all regular shares that are available for trading. Based on its trading volume, it would take traders 9.96 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short
As the 19th Benzinga Cannabis Capital Conference, returns (Oct. 8-9) in Chicago, gathering top CEOs, investors, and leaders in the cannabis industry, let’s scroll through the latest leadership changes within the space. Get your tickets now before prices go up by following this link. Cannabis Board Updates Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors. Auxly Cannabis Group Inc. (TSX:XLY) (OTCQB:CBWTF) said on Tuesday that each of the directors listed as a nominee in the circular was elected as a director of the company, including: Genevieve Young; Hugo Alves; Troy Grant; Vikram Bawa; and Conrad Tat
Simply Solventless Concentrates Ltd. (TSXV:HASH) is acquiring Lifeist Wellness Inc.'s (TSXV:LFST) (FRANKFURT: M5B) (OTC:LFSWF) subsidiary CannMart Inc. What Happened The Calgary, Alberta-based company said on Wednesday that it has entered into a services agreement regarding the operations of CannMart and a share purchase agreement with Lifeist Wellness Inc. to acquire all of the shares of CannMart. See also: Canadian Company Lifeist Says Farewell To Cannabis Business Unit, Turns To Nutraceuticals Key terms of the services agreement are as follows: SCC will receive the benefit of 100% of CannMart’s revenue, less a service fee of 10% of net revenue; SSC will help to manage
SCOTTSDALE, Ariz., March 12, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Teresa DeLuca has joined the company's board of directors. Dr. DeLuca is a psychiatrist and accomplished physician executive with over 20 years of leadership experience, having held senior executive leadership roles at Magellan Health, Humana and Walgreens, and brings extensive healthcare operations and clinical management expertise to LifeStance's board of directors. "Dr. DeLuca's background
SCOTTSDALE, Ariz., Jan. 19, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Ujjwal Ramtekkar will join the company as Chief Medical Officer, effective January 22, 2024. He will lead all clinical services, ensuring that LifeStance's psychiatric and psychotherapy clinicians are enabled to deliver high-quality, personalized patient care that meets and exceeds professional standards. "Dr. Ramtekkar is an experienced physician executive with a demonstrated track record of d
SCOTTSDALE, Ariz., Nov. 3, 2022 /PRNewswire/ -- LifeStance Health (NASDAQ:LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that effective November 10, 2022, J. Michael Bruff, currently Chief Financial Officer, will take on a new role as Business Transformation Officer. David Bourdon will join the company and succeed Bruff as Chief Financial Officer. Both executives will report directly to Ken Burdick, Chairman and Chief Executive Officer, LifeStance. During LifeStance's long-range planning process, the company's leadership team ide
SCOTTSDALE, Ariz., July 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2024 earnings release before the market opens on Thursday, August 8, 2024. LifeStance will host a live earnings conference call to discuss second quarter results on August 8, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 1488997, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance
SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2024 earnings release before the market opens on Thursday, May 9, 2024. LifeStance will host a live earnings conference call to discuss first quarter results on May 9, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3005519, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor Re
SCOTTSDALE, Ariz., Feb. 07, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2023 earnings release before the market opens on Wednesday, February 28, 2024. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 28, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 7685503, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and P